Intuitive Surgical Inc
Research Intuitive Surgical Inc (ISRG) on Bullrun: valuation model: 6.3% overvalued, market cap USD 131.59B, P/E 42.6. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerISRG
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyUSD
- Valuation signal6.3% overvalued
- Market capUSD 131.59B
- P/E42.6
- Financial periodQ2 2026
- RevenueUSD 2.89B
- Net incomeUSD 818.10M
- Free cash flowUSD 948.40M
- Gross margin67.8%
Valuation Snapshot
Bullrun's latest valuation model marks Intuitive Surgical Inc as 6.3% overvalued; latest market cap is USD 131.59B; P/E is 42.6.
Peer valuation comparison
Latest P/E is 42.62x versus a Healthcare sector median of 24.46x (74.2% above).
Latest P/E is 42.62x versus a United States median of 24.87x (71.4% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 10.06B | USD 2.86B | USD 2.49B | 66.0% | 7.87 | USD 3.37B | n/a | USD 17.82B |
| FY2024 | USD 8.35B | USD 2.32B | USD 1.30B | 67.5% | 6.42 | USD 2.03B | n/a | USD 16.43B |
| FY2023 | USD 7.12B | USD 1.80B | USD 749.60M | 66.4% | 5.03 | USD 2.75B | n/a | USD 13.31B |
| FY2022 | USD 6.22B | USD 1.32B | USD 958.40M | 67.4% | 3.65 | USD 1.58B | n/a | USD 11.04B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 131.59B | 42.6 | n/a | n/a |
| 2025 | 2025-12-31 | USD 201.11B | 71.9 | n/a | n/a |
| 2024 | 2024-12-31 | USD 186.13B | 81.4 | n/a | n/a |
| 2023 | 2023-12-29 | USD 118.77B | 79.4 | n/a | n/a |
| 2022 | 2022-12-30 | USD 93.77B | 70.2 | n/a | n/a |
| 2021 | 2021-12-31 | USD 128.52B | 77.1 | n/a | n/a |
About Intuitive Surgical Inc
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung.
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Intuitive Surgical Inc overvalued or undervalued?
Bullrun's valuation model currently marks Intuitive Surgical Inc as 6.3% overvalued.
What is Intuitive Surgical Inc's market cap?
Intuitive Surgical Inc's market capitalization is USD 131.59B.
What is Intuitive Surgical Inc's P/E ratio?
Intuitive Surgical Inc's price-to-earnings (P/E) ratio is 42.6.
What does Intuitive Surgical Inc do?
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung.